Transcriptional and conformational changes of the tau molecule in Alzheimer's disease

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492 · see citing works

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780 · see citing works

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · see citing works

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · see citing works

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,462 · see citing works

The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease

Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380 · see citing works

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · see citing works

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · see citing works

Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif ( ³⁰⁶ VQIVYK ³¹¹ ) forming β structure

von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021 · see citing works

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · see citing works

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · see citing works

Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly

Cleveland, D. W., Hwo, S. Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90214-5 · Cited by 881 · see citing works

Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666 · see citing works

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

Killiany, R., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Sándor, T., Jolesz, F. A., Tanzi, R. E., Jones, K. J., Hyman, B. T., & Albert, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 659 · see citing works

Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure

von Bergen�, M., Barghorn, S., Li, L., Marx, A., Biernat, J., Mandelkow, E., & Mandelkow�, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105196200 · Cited by 590 · see citing works

Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment

Guillozet-Bongaarts, A. L., Weıntraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 572 · see citing works

Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Schweers, O., Schönbrunn, E., Marx, A., & Mandelkow�, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51080-8 · Cited by 569 · see citing works

Phosphorylation that Detaches Tau Protein from Microtubules (Ser262, Ser214) Also Protects It against Aggregation into Alzheimer Paired Helical Filaments

Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E., & Mandelkow, E.-M. (1999) · Biochemistry · doi:10.1021/bi981874p · Cited by 564 · see citing works

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V., Bird, T., & Schellenberg, G. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.10.5598 · Cited by 545 · see citing works

Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

Clark, L. N., Poorkaj, P., Wszolek, Z., Geschwind, D., Nasreddine, Z. S., Miller, B. L., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.22.13103 · Cited by 488 · see citing works

Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly

Hasegawa, M., Smith, M. J., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01217-4 · Cited by 482 · see citing works

Frontotemporal Dementia and Corticobasal Degeneration in a Family with a P301S Mutation in Tau

Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., Morbin, M., Primavera, A., Carella, F., Solaro, C., et al. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00011 · Cited by 450 · see citing works

High Prevalence of Mutations in the Microtubule-Associated Protein Tau in a Population Study of Frontotemporal Dementia in the Netherlands

Rizzu, P., Swieten, J. C. V., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M. F., Hillebrand, M., Ravid, R., Oostra, B. A., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302256 · Cited by 428 · see citing works

The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology

Carmel, G., Mager, E. M., Binder, L. I., & Kuret, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32789 · Cited by 402 · see citing works

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study

Riley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002) · Annals of Neurology · doi:10.1002/ana.10161 · Cited by 392 · see citing works

Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis

Fend, F., Emmert‐Buck, M. R., Chuaqui, R. F., Cole, K. A., Lee, J., Liotta, L. A., & Raffeld, M. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65251-0 · Cited by 378 · see citing works

Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease

Buée, L., & Delacourte, A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00550.x · Cited by 361 · see citing works

Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles

Trinczek, B., Ebneth, A., Mandelkow, E.-M., & Mandelkow, E. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.14.2355 · Cited by 344 · see citing works

Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

Barghorn, S., & Mandelkow, E. (2002) · Biochemistry · doi:10.1021/bi026469j · Cited by 341 · see citing works

C-terminal inhibition of tau assembly in vitro and in Alzheimer’s disease

Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V. L., Berry, R. W., Kuret, J., & Binder, L. I. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.21.3737 · Cited by 326 · see citing works

Conformational change as one of the earliest alterations of tau in Alzheimer's disease

Weaver, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00157-3 · Cited by 310 · see citing works

Tau domains, phosphorylation, and interactions with microtubules

Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B., & Mandelkow, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00025-a · Cited by 308 · see citing works

5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10

Grover, A., Houlden, H., Baker, M. C., Adamson, J. L., Lewis, J. M., Prihar, G., Pickering-Brown, S. M., Duff, K., & Hutton, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15134 · Cited by 300 · see citing works

Microtubule-Associated Protein Tau

Yen, S.-H. C., Nacharaju, P., Ko, L., Kenessey, Á., & Liu, W.-K. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50012-9 · Cited by 284 · see citing works

Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene

Stanford, P. M., Halliday, G. M., Brooks, W. S., Kwok, J. B. J., Storey, C. E., Creasey, H., Morris, J. G. L., Fulham, M. J., & Schofield, P. R. (2000) · Brain · doi:10.1093/brain/123.5.880 · Cited by 262 · see citing works

Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

Goedert, M., Spillantini, M. G., & Crowther, R. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1983 · Cited by 255 · see citing works

Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies

Love, S., Saitoh, T., Quijada, S., Cole, G. M., & Terry, R. D. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198807000-00001 · Cited by 242 · see citing works

Structural and Functional Differences between 3-Repeat and 4-Repeat Tau Isoforms

Goode, B. L., Chau, M. F., Denis, P. E., & Feinstein, S. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007489200 · Cited by 241 · see citing works

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies

de Silva, R., Lashley, T., Gibb, G., Hanger, D. P., Hope, A., Reid, A. R., Bandopadhyay, R., Utton, M. A., Strand, C., Jowett, T. P., et al. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00463.x · Cited by 220 · see citing works

TauGene Mutation G389R Causes a Tauopathy with Abundant Pick Body-like Inclusions and Axonal Deposits

Murrell, J. R., Spillantini, M. G., Zolo, P., Guazzelli, M., Smith, M. J., Hasegawa, M., Redi, F., Crowther, R. A., Pietrini, P., Ghetti, B. F., et al. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199912000-00002 · Cited by 205 · see citing works

Tau gene mutation in familial progressive subcortical gliosis

Goedert, M., Spillantini, M. G., Crowther, R. A., Chen, S. G., Parchi, P., Tabaton, M., Lanska, D. J., Markesbery, W. R., Wilhelmsen, K. C., Dickson, D. W., et al. (1999) · Nature Medicine · doi:10.1038/7454 · Cited by 187 · see citing works

Alz‐50 Antibody recognizes alzheimer‐related neuronal changes

Hyman, B. T., Hoesen, G. W. V., Wolozin, B. L., Davies, P., Vogt, L. J., & Damasio, A. R. (1988) · Annals of Neurology · doi:10.1002/ana.410230410 · Cited by 176 · see citing works

A distinct familial presenile dementia with a novel missense mutation in the tau gene

Iijima, M., Tabira, T., Poorkaj, P., Schellenberg, G. D., Trojanowski, J. Q., Lee, V. M. ‐., Schmidt, M. L., Takahashi, K., Nabika, T., Matsumoto, T., et al. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00010 · Cited by 159 · see citing works

TauGene Mutation K257T Causes a Tauopathy Similar to Pick's Disease

Rizzini, C., Goedert, M., Hodges, J. R., Smith, M. J., Jakes, R., Hills, R., Xuereb, J. H., Crowther, R. A., & Spillantini, M. G. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.990 · Cited by 159 · see citing works

Sporadic Pick's disease: A tauopathy characterized by a spectrum of pathological τ isoforms in gray and white matter

Zhukareva, V., Mann, D., Pickering-Brown, S., Uryu, K., Shuck, T., Shah, K., Grossman, M., Miller, B. L., Hulette, C., Feinstein, S., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10222 · Cited by 157 · see citing works

Kinesin motors and disease

Mandelkow�, E., & Mandelkow, E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02400-5 · Cited by 134 · see citing works

Tau Phosphorylation, Tangles, and Neurodegeneration

Geschwind, D. H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00681-0 · Cited by 129 · see citing works

Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia

Stanford, P. M. (2003) · Brain · doi:10.1093/brain/awg090 · Cited by 125 · see citing works

Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease

Jicha, G. A., Berenfeld, B., & Davies, P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 123 · see citing works

α-Helix Structure in Alzheimer's Disease Aggregates of Tau-Protein

Sadqi, M., Hernández, F., Pan, U., Pérez, M., Schaeberle, M. D., Ávila, J., & Muñoz, V. (2002) · Biochemistry · doi:10.1021/bi025777e · Cited by 117 · see citing works

Amyloid Precursor Protein Associates with a Nicastrin-Dependent Docking Site on the Presenilin 1–γ-Secretase Complex in Cells Demonstrated by Fluorescence Lifetime Imaging

Berezovska, O., Ramdya, P. P., Skoch, J. M., Wolfe, M. S., Bacskai, B. J., & Hyman, B. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04560.2003 · Cited by 108 · see citing works

Single Molecule Profiling of Alternative Pre-mRNA Splicing

Zhu, J., Shendure, J., Mitra, R. D., & Church, G. M. (2003) · Science · doi:10.1126/science.1085792 · Cited by 98 · see citing works

Complex Regulation of Tau Exon 10, Whose Missplicing Causes Frontotemporal Dementia

Gao, Q., Memmott, J. E., Lafyatis, R., Stamm, S., Screaton, G. R., & Andreadis, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740490.x · Cited by 87 · see citing works

Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R

van Herpen, E., Rosso, S. M., Serverijnen, L., Yoshida, H., Breedveld, G. J., van de Graaf, R., Kamphorst, W., Ravid, R., Willemsen, R., Dooijes, D., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10721 · Cited by 83 · see citing works

Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy

Tabatonm, M., Whitehouse, P. J., Perry, G. L., Davies, P., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240309 · Cited by 75 · see citing works

Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy

Liu, W.-K., Le, T. V., Adamson, J. L., Baker, M., Cookson, N., Hardy, J., Hutton, M. L., Yen, S.-H. C., & Dickson, D. W. (2001) · Annals of Neurology · doi:10.1002/ana.1159 · Cited by 69 · see citing works

A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy

Grover, A., England, E., Baker, M., Sahara, N., Adamson, J. L., Granger, B., Houlden, H., Passant, U., Yen, S.-H. C., Deture, M. A., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00393-5 · Cited by 62 · see citing works

Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA

Yasojima, K., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01486-9 · Cited by 51 · see citing works

Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration

Takanashi, M., Mori, H., Arima, K., Mizuno, Y., & Hattori, N. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00382-0 · Cited by 46 · see citing works

Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites.

Liu, W.-K., Dickson, D. W., & Yen, S.-H. C. (1993) · PubMed · Cited by 45 · see citing works

Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation

Ingelson, M., Vanmechelen, E., & Lannfelt, L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13218-3 · Cited by 45 · see citing works

The Conformations of Filamentous and Soluble Tau Associated with Alzheimer Paired Helical Filaments

Goux, W. J. (2002) · Biochemistry · doi:10.1021/bi016079h · Cited by 42 · see citing works

A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease

Ishizawa, K., Ksiȩżak-Reding, H., Davies, P., Delacourte, A., Tiseo, P. J., Yen, S. H., & Dickson, D. W. (2000) · Acta Neuropathologica · doi:10.1007/s004019900177 · Cited by 42 · see citing works

Tau Protein in Familial and Sporadic Diseases

Yancopoulou, D., & Spillantini, M. G. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:37 · Cited by 40 · see citing works

Microtubule-associated protein tau epitopes are present in fiber lesions in diverse muscle disorders.

Lübke, U., Six, J., Villanova, M., Boons, J., Vandermeeren, M., Ceuterick, C., Cras, P. P., & Martin, J. (1994) · PubMed Central · Cited by 30 · see citing works

Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics

Deerlin, V. M. V., Gill, L. H., Farmer, J. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Clinical Chemistry · doi:10.1373/49.10.1717 · Cited by 21 · see citing works

IMMUNOELECTRON MICROSCOPY OF ALZHEIMER AND PICK BRAIN TISSUE LABELLED WITH THE MONOCLONAL ANTIBODY ALZ–50

Love, S., Burrola, P., Terry, R. D., & Wiley, C. A. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01224.x · Cited by 20 · see citing works

Monitoring Proteins in Intact Cells

Berezovska, O., Bacskai, B. J., & Hyman, B. T. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.23.pe14 · Cited by 16 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8249(200012)48:6

Untitled work

(1997) · doi:10.1002/(sici)1097-4547(19970415)48:2

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

Mufson, E. J., Counts, S., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 589 · see citing works

Structure and Pathology of Tau Protein in Alzheimer Disease

Kolarova, M., García‐Sierra, F., Bartoš, A., Říčný, J., & Řı́pová, D. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/731526 · Cited by 473 · see citing works

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 407 · see citing works

The complexity of tau in Alzheimer’s disease

Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 374 · see citing works

Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein

Dorval, V., & Fraser, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510127200 · Cited by 319 · see citing works

Tau pathophysiology in neurodegeneration: a tangled issue

Spires‐Jones, T. L., Stoothoff, W. H., de Calignon, A., Jones, P., & Hyman, B. T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.007 · Cited by 317 · see citing works

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

Singh, B., Day, C. M., Abdella, S., & Garg, S. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.047 · Cited by 245 · see citing works

Traumatic Brain Injury Induces Tau Aggregation and Spreading

Edwards, G., Zhao, J., Dash, P. K., Soto, C., & Moreno-Gonzalez, I. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2018.6348 · Cited by 195 · see citing works

Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer’s Disease

Baptista, F. I., Henriques, A. G., Silva, A. M. S., Wiltfang, J., & Silva, O. A. B. D. C. E. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400213r · Cited by 189 · see citing works

Salivary biomarkers for the diagnosis and monitoring of neurological diseases

Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Sadier, N. S. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 170 · see citing works

Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease

Jellinger, K. A., & Attems, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0156-7 · Cited by 157 · see citing works

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease

Thapa, P., Upadhyay, S. P., Suo, W. Z., Singh, V., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104681 · Cited by 147 · see citing works

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Kurbatskaya, K., Phillips, E. C., Croft, C. L., Dentoni, G., Hughes, M. M., Wade, M. A., Al-Sarraj, S., Troakes, C., O'Neill, M., Perez-Nievas, B., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0299-2 · Cited by 132 · see citing works

Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy

Bandyopadhyay, B., Li, G., Yin, H., & Kuret, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700192200 · Cited by 133 · see citing works

Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

Götz, J., Ittner, L. M., & Kins, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03955.x · Cited by 114 · see citing works

Shift in the ratio of three‐repeat tau and four‐repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111 · see citing works

Are Tangles as Toxic as They Look?

Spires‐Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., & Hyman, B. T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9566-7 · Cited by 110 · see citing works

Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation

Gomes, L. A., Uytterhoeven, V., Lopez-Sanmartin, D., Tomé, S. O., Tousseyn, T., Vandenberghe, R. R., Vandenbulcke, M., Arnim, C. A. F. V., Verstreken, P., & Thal, D. R. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02251-6 · Cited by 74 · see citing works

Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection

Goldoni, R., Dolci, C., Boccalari, E., Inchingolo, F., Paghi, A., Strambini, L. M., Galimberti, D., & Tartaglia, G. M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101587 · Cited by 78 · see citing works

Calpain Dysregulation in Alzheimer’s Disease

Ferreira, A. (2012) · ISRN Biochemistry · doi:10.5402/2012/728571 · Cited by 61 · see citing works

ATP Controls the Aggregation of Aβ 16–22 Peptides

Pal, S., & Paul, S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b10175 · Cited by 62 · see citing works

GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25–35 in a rat model of Alzheimer's disease

Alireza, M. S., Nikbakht, F., Nia, H. H., Golab, F., Khadem, Y., Barati, M., & Vazifekhah, S. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102200 · Cited by 61 · see citing works

MAPping out distribution routes for kinesin couriers

Atherton, J., Houdusse, A., & Moores, C. A. (2013) · Biology of the Cell · doi:10.1111/boc.201300012 · Cited by 54 · see citing works

Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate

Bondulich, M. K., Guo, T., Meehan, C., Manion, J., Martin, T. R., Mitchell, J. C., Hortobágyi, T., Yankova, N., Stygelbout, V., Brion, J., et al. (2016) · Brain · doi:10.1093/brain/aww137 · Cited by 54 · see citing works

Amyloid β1-42 (Aβ1-42) Induces the CDK2-Mediated Phosphorylation of Tau through the Activation of the mTORC1 Signaling Pathway While Promoting Neuronal Cell Death

Lee, K. H., Lee, S., Lee, H. J., Choi, G. E., Jung, Y. H., Kim, D. I., Gabr, A. A., Ryu, J. M., & Han, H. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00229 · Cited by 52 · see citing works

The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease

Pawlik, P., & Błochowiak, K. J. (2021) · Diagnostics · doi:10.3390/diagnostics11020371 · Cited by 48 · see citing works

An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization

Rane, J. S., Kumari, A. R., & Panda, D. (2019) · Biochemical Journal · doi:10.1042/bcj20190042 · Cited by 47 · see citing works

Glymphatic and meningeal lymphatic dysfunction in Alzheimer's disease: Mechanisms and therapeutic perspectives

Ding, J., Zhao, C., Hao, X., & Jiao, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70709 · Cited by 42 · see citing works

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin

Ubhi, K. K., Rockenstein, E. M., Doppler, E., Mante, M., Adame, A., Patrick, C., Trejo, M., Crews, L. A., Paulino, A., Moessler, H., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0505-4 · Cited by 42 · see citing works

No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer’s disease brain

Ingelsson, M., Ramasamy, K., Cantuti‐Castelvetri, I., Skoglund, L., Matsui, T., Orne, J. D., Kowa, H., Raju, S., Vanderburg, C. R., Augustinack, J. C., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0095-3 · Cited by 41 · see citing works

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies

Ubhi, K. K., Shaibah, H., Newman, T. A., Shepherd, D., & Mudher, A. K. (2007) · Invertebrate Neuroscience · doi:10.1007/s10158-007-0052-4 · Cited by 39 · see citing works

Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease

Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 37 · see citing works

Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease

García‐Sierra, F., Jarero-Basulto, J. J., Krištofíková, Z., Majer, E., Binder, L. I., & Řı́pová, D. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00525.x · Cited by 34 · see citing works

Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease

Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 33 · see citing works

Potency of a tau fibrillization inhibitor is influenced by its aggregation state

Congdon, E. E., Necula, M., Blackstone, R. D., & Kuret, J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.05.004 · Cited by 30 · see citing works

Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology

Bashir, S., Aiman, A., Shahid, M., Chaudhary, A. A., Sami, N., Basir, S. F., Hassan, M. I., & Islam, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102276 · Cited by 31 · see citing works

Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6–12 Month Global Outcomes

Rubenstein, R., McQuillan, L. E., Wang, K., Robertson, C. S., Chang, B., Yang, Z., Xu, H., Williamson, J. B., & Wagner, A. K. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0479 · Cited by 28 · see citing works

Neuroprotective Effects of Flavonoid Compounds on Neuronal Death Associated to Alzheimer’s Disease

Sureda, A., Capó, X., & Tejada, S. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171226103237 · Cited by 25 · see citing works

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies

Badiola, N., Suárez‐Calvet, M., & Lleó, A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793237403 · Cited by 25 · see citing works

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 21 · see citing works

Screening Techniques for Drug Discovery in Alzheimer’s Disease

Maniam, S., & Maniam, S. (2024) · ACS Omega · doi:10.1021/acsomega.3c07046 · Cited by 21 · see citing works

4-Hydroxyisophthalic acid from Decalepis hamiltonii rescues the neurobehavioral deficit in transgenic Drosophila model of taupathies

Haddadi, M., Jahromi, S. R., Nongthomba, U., Shivanandappa, T., & Ramesh, S. R. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.09.007 · Cited by 20 · see citing works

Sunset yellow degradation product, as an efficient water-soluble inducer, accelerates 1N4R Tau amyloid oligomerization: In vitro preliminary evidence against the food colorant safety in terms of “Triggered Amyloid Aggregation”

Ojaghi, S., Mohammadi, S., Amani, M., Ghobadi, S., Bijari, N., Esmaeili, S., & Khodarahmi‬, R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104123 · Cited by 18 · see citing works

Disease Modifying Monoclonal Antibodies and Symptomatic Pharmacological Treatment for Alzheimer’s Disease

Qi, X., Nizamutdinov, D., Yi, S. S., Wu, E., & Huang, J. H. (2024) · Biomedicines · doi:10.3390/biomedicines12112636 · Cited by 17 · see citing works

Conformational Changes and Cleavage; are these Responsible for the tau Aggregation in Alzheimer‘s Disease?

Mondragón‐Rodríguez, S., Basurto‐Islas, G., Binder, L. I., & García‐Sierra, F. (2008) · Future Neurology · doi:10.2217/14796708.4.1.39 · Cited by 17 · see citing works

TGIF1 splicing variant 8 is overexpressed in oral squamous cell carcinoma and is related to pathologic and clinical behavior

Libório‐Kimura, T. N., Ferreira, E. N., Xavier, F. C. D. A., Carraro, D. M., Kowalski, L. P., Soares, F. A., & Nunes, F. D. (2013) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2013.07.014 · Cited by 16 · see citing works

Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases

Janus, C. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00375.x · Cited by 15 · see citing works

Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer’s disease brains

Ibarra-Bracamontes, V., Escobar‐Herrera, J., Krištofíková, Z., Řı́pová, D., Florán, B., & García‐Sierra, F. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146953 · Cited by 14 · see citing works

Expression Profile Analysis of Brain Aging

Ginsberg, S. D. (2007) · CRC Press eBooks · doi:10.1201/9781420005523-7 · Cited by 14 · see citing works

The unique neuropathological vulnerability of the human brain to aging

Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 14 · see citing works

Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse

Andrés‐Benito, P., Flores, Á., Busquet-Areny, S., Carmona, M., Ausín, K., Cartas‐Cejudo, P., Lachén‐Montes, M., del Rı́o, J. A., Fernández‐Irigoyen, J., Santamaría, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076559 · Cited by 10 · see citing works

DNA Methylation and Alzheimer’s Disease

van Groen, T. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_17 · Cited by 9 · see citing works

Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review

Premkumar, T., & Sajitha Lulu, S. (2022) · Neurochemical Journal · doi:10.1134/s1819712422040183 · Cited by 8 · see citing works

Kognitive Störungen: Koma, Delir, Demenz

Förstl, H. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_5 · Cited by 8 · see citing works

Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer’s Disease Brain

Horta‐López, P. H., Mendoza-Franco, G., Rodríguez‐Cruz, F., Torres-Cruz, F. M., Hernández, E., Jarero-Basulto, J. J., Říčný, J., Florán, B., & García‐Sierra, F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.01.002 · Cited by 7 · see citing works

Metal Ions and Alzheimer's Disease

Adlard, P. A., & Bush, A. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_15 · Cited by 6 · see citing works

The Role of Tau Protein in Diseases

Das Bhaskar, C. (2018) · Annals of Advances in Chemistry · doi:10.29328/journal.aac.1001010 · Cited by 6 · see citing works

Protein Aggregation Disorders

Outeiro, T. F., McLean, P. J., & Hyman, B. T. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50012-8 · Cited by 5 · see citing works

The Determinant of Tau Spreading in Alzheimer’s Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?

Riku, Y., Brion, J., Ando, K., Uchihara, T., & Iwasaki, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412088 · Cited by 5 · see citing works

Intra-hippocampal cis-P tau microinjection induces long-term changes in behavior and synaptic plasticity in mice

Bakhtiarzadeh, F., Shahpasand, K., Shojaei, A., Fathollahi, Y., & Mirnajafi‐Zadeh, J. (2023) · Behavioral and Brain Functions · doi:10.1186/s12993-023-00211-0 · Cited by 4 · see citing works

Tau and Amyloid- Conformational Change to -Sheet Structures as Effectors in the Development of Alzheimer's Disease

Anda-Hernández, M. A. D., León, K. I. L.-D., Mena, R., Campos‐Peña, V., & Meraz‐Ríos, M. A. (2012) · InTech eBooks · doi:10.5772/37909 · Cited by 3 · see citing works

The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study

Ochneva, A., Zakurazhnaya, V., Zorkina, Y., Abramova, O. V., Ushakova, V. M., Tsurina, A. M., Golubeva, E., Gurina, O. I., Berdalin, A., Syunyakov, T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251350385 · Cited by 2 · see citing works

Face processing in persons with and without Alzheimer's disease

Winchester, J. (2009) · Cited by 2 · see citing works

Chapter 11 Biomedical FRET–FLIM applications

Jones, P., Bacskai, B. J., & Hyman, B. T. (2009) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)00011-9 · Cited by 2 · see citing works

Intracellular Calcium Assays in Dissociated Primary Cortical Neurons

Kaur, N., Thompson, D. V., Judd, D., Piper, D. R., & Mastro, R. G. D. (2009) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-60761-292-6_7 · Cited by 2 · see citing works

Salivary biomarkers for neurodegenerative disorder for biomedical sensing

Singhal, A., Devi, R., Parihar, A., & Khan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00011-9 · Cited by 1 · see citing works

Research progress on biomarkers of traumatic brain injury

Shen, X., Cheng, S., Chen, S., Wang, M., Li, T., Xu, W., Zhang, Y., Yuan, P., & Shi, L. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70173 · Cited by 1 · see citing works

Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease

García‐Sierra, F., Basurto‐Islas, G., Jarero-Basulto, J., Hugo, C., Cruz, F. M. T., Cortés, H., Rojas, H., Krištofíková, Z., Řı́pová, D., Luna‐Muñoz, J., et al. (2011) · InTech eBooks · doi:10.5772/17077 · Cited by 1 · see citing works

Identificação de variantes de splicing sob influência da alta expressão do oncogene ERBB2 em câncer de mama

Ferreira, E. N. (2010) · doi:10.11606/t.41.2010.tde-22112010-205937

Non‐amyloid Approaches To Alzheimer's Disease

Veng, L., Savage, M. J., Barrow, J. C., & Zerbinatti, C. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc253

Improved Behavioral Response as a Valid Biomarker for Drug Screening Program in Transgenic Rodent Models of Tauopathies

Korenova, M., & Stožická, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9378-2

The Cytoskeleton as a Pharmacological Target in Neurodegenerative Diseases

Oz, S., & Gozes, I. (2012) · Neuromethods · doi:10.1007/978-1-62703-266-7_8

Identifying stage-specific markers of Alzheimer's disease using quantitative proteomics

Yagensky, O. (2018) · doi:10.53846/goediss-7052

Salivary Biomarkers in Neurologic Diseases

Zian, Z., & Bouhoudan, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-37681-9_7

La place des biomarqueurs dans les essais de prévention de la maladie d'Alzheimer

Delrieu, J. (2021) · doi:10.70675/2b5f4719z01f9z4376z9dabzd5a185dc4d79

Advancing Strain‐Specific Immunotherapy for Alzheimer's Disease and Tauopathies

Priya, E. S., Vasanth, S., Taj, T., Ameen, M. P. M., Danam, S. S., & Kumar, M. V. (2026) · doi:10.1002/9781394336241.ch3

Neurofluid Biomarker Sensors: Integrated Design Strategies From Molecular Recognition to Precision Neurological Diagnosis

Li, T., Pan, G., Wang, Y., Zou, X., & Yang, H. (2026) · Advanced Sensor Research · doi:10.1002/adsr.70209

Tau gene mutations and neurodegeneration

Goedert, M., & Spillantini, M. G. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670059 · Cited by 57 · see citing works

Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer’s disease

Goedert, M., & Spillantini, M. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00037-5 · Cited by 168 · see citing works

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

Spillantini, M. G., Swieten, J. C. V., & Goedert, M. (2000) · Neurogenetics · doi:10.1007/s100489900084 · Cited by 134 · see citing works

Tau mutations in familial frontotemporal dementia

Spillantini, M. G. (2000) · Brain · doi:10.1093/brain/123.5.857 · Cited by 57 · see citing works

Tau mutations in FTDP-17 and their relevance for Alzheimer's disease

Goedert, M. (2000) · Biochemical Society Transactions · doi:10.1042/bst028a015a